Head and neck squamous cell carcinoma: a potential therapeutic target for the Wnt signaling pathway

被引:0
|
作者
Khosrow Siamak Houschyar
Mimi R. Borrelli
Susanne Rein
Christian Tapking
Daniel Popp
Alen Palackic
Behrus Puladi
Mark Ooms
Madeline Houschyar
Ludwik K. Branski
Laurenz Schmitt
Ali Modabber
Albert Rübben
Frank Hölzle
Amir S. Yazdi
机构
[1] RWTH University Hospital Aachen,Department of Dermatology and Allergology
[2] Stanford School of Medicine,Division of Plastic and Reconstructive Surgery, Department of Surgery
[3] Klinikum St. Georg,Department of Plastic and Hand Surgery
[4] University of Heidelberg,Burn Center
[5] Medical University of Graz,Department of Hand, Plastic and Reconstructive Surgery, Burn Trauma Center, BG Trauma Center Ludwigshafen
[6] University Hospital RWTH,Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery
[7] Martin Luther University of Halle,Department of Oral and Maxillofacial Surgery
[8] University of Texas Medical Branch,Institute of Agricultural and Nutrition Sciences
来源
关键词
Stem cells; Carcinoma; Wnt signaling;
D O I
暂无
中图分类号
学科分类号
摘要
Squamous cell carcinoma (SCC) of the head and neck region accounts for 3% of all tumors worldwide. The incidence is higher in men, with most carcinomas found in the oral cavity. At the point of initial diagnosis, distant metastases are rare. The Wnt signaling pathway is critically involved in cell development and stemness and has been associated with SCC. Understanding precisely how Wnt signaling regulates SCC progression and how it can, therefore, be modulated for the therapeutic benefit has enormous potential in the treatment of head and neck SCC. In this review, we will describe the underlying mechanisms of Wnt signaling and outline how Wnt signaling controls cellular processes both in homeostasis and in the development and progression of SCC.
引用
收藏
页码:863 / 871
页数:8
相关论文
共 50 条
  • [41] Pdcd10 is a promising therapeutic target for head and neck squamous cell carcinoma
    Sundaresan, Manu
    Cheng, Xiangying
    Wing, Claudia
    von Kumberg, Alexander
    Jochum, Elena
    Singh, Alka
    Kainov, Joseph
    Zhao, Piao
    Sidahmed, Mohammed
    Pearson, Alexander T.
    Rosenberg, Ari J.
    Agrawal, Nishant
    Le Shen
    Izumchenko, Evgeny
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [42] The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma
    Fukusumi, T.
    Califano, J. A.
    [J]. JOURNAL OF DENTAL RESEARCH, 2018, 97 (06) : 645 - 653
  • [43] The Wnt signaling pathway: a potential therapeutic target against cancer
    Ghosh, Noyel
    Hossain, Uday
    Mandal, Ankita
    Sil, Parames C.
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1443 (01) : 54 - 74
  • [44] The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis
    Zhao, Yu-Yue
    Yu, Guang-Tao
    Xiao, Ting
    Hu, Jian
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (05): : 881 - 887
  • [45] Unveiling the potential of angiotensin-converting enzyme as a therapeutic target in head and neck squamous carcinoma
    Gomes, Emisael Stenio Batista
    de Souza, Marcela Goncalves
    da Rocha, Rogerio Goncalves
    Rodrigues, Lincoln Valerio Andrade
    Ruas, Maria Isabela Campos
    Guimaraes, Osvaldo Sena
    Farias, Lucyana Conceicao
    de Paula, Alfredo Mauricio Batista
    Santos, Sergio Henrique Sousa
    Guimaraes, Andre Luiz Sena
    [J]. GENE REPORTS, 2024, 34
  • [46] MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma
    Zhuang, Zehang
    Yu, Pei
    Xie, Nan
    Wu, Yue
    Liu, Haichao
    Zhang, Ming
    Tao, Yifan
    Wang, Weiwang
    Yin, Hanqi
    Zou, Bin
    Hou, Jinsong
    Liu, Xiqiang
    Li, Jiong
    Huang, Hongzhang
    Wang, Cheng
    [J]. THERANOSTICS, 2020, 10 (03): : 1433 - 1453
  • [47] MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
    Jain, Ankit P.
    Patel, Krishna
    Pinto, Sneha
    Radhakrishnan, Aneesha
    Nanjappa, Vishalakshi
    Kumar, Manish
    Raja, Remya
    Patil, Arun H.
    Kumari, Anjali
    Manoharan, Malini
    Karunakaran, Coral
    Murugan, Saktivel
    Prasad, T. S. Keshava
    Chang, Xiaofei
    Mathur, Premendu Prakash
    Kumar, Prashant
    Gupta, Ravi
    Gupta, Rohit
    Khanna-Gupta, Arati
    Sidransky, David
    Chatterjee, Aditi
    Gowda, Harsha
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [48] MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
    Ankit P. Jain
    Krishna Patel
    Sneha Pinto
    Aneesha Radhakrishnan
    Vishalakshi Nanjappa
    Manish Kumar
    Remya Raja
    Arun H. Patil
    Anjali Kumari
    Malini Manoharan
    Coral Karunakaran
    Saktivel Murugan
    T. S. Keshava Prasad
    Xiaofei Chang
    Premendu Prakash Mathur
    Prashant Kumar
    Ravi Gupta
    Rohit Gupta
    Arati Khanna-Gupta
    David Sidransky
    Aditi Chatterjee
    Harsha Gowda
    [J]. Scientific Reports, 9
  • [49] UCHL1 promotes proliferation and metastasis in head and neck squamous cell carcinoma and could be a potential therapeutic target
    Zhang, Dahe
    Fu, You
    Tian, Guocai
    Li, Jiayi
    Shang, Dihua
    Zhou, Shanghui
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2022, 133 (06): : 684 - 697
  • [50] Potential biomarkers for head and neck squamous cell carcinoma
    Brown, JJ
    Xu, H
    Nishitani, J
    Mohammed, H
    Osborne, R
    Teklehaimanot, S
    Gill, G
    Liu, X
    [J]. LARYNGOSCOPE, 2003, 113 (03): : 393 - 400